An advanced IVB lung adenocarcinoma patient with KRAS mutations, benefited from camrelizumab combined with anti- angiogenic agents for therapy: a case report
Preprint in Research Square (January 2024)
The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.
Preprint in Research Square (January 2024)
Article in Biomedicines (February 2023)
Article in Frontiers in Microbiology (June 2022)